LCTX icon

Lineage Cell Therapeutics

76 hedge funds and large institutions have $49.8M invested in Lineage Cell Therapeutics in 2020 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 13 increasing their positions, 24 reducing their positions, and 20 closing their positions.

Holders
76
Holders Change
-18
Holders Change %
-19.15%
% of All Funds
1.54%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.06%
New
2
Increased
13
Reduced
24
Closed
20
Calls
$67K
Puts
$1K
Net Calls
+$66K
Net Calls Change
-$30K
Name Market Value Shares Shares
Change
Shares
Change %
BDS
76
Banco de Sabadell
Florida
-20,000 Closed
GCP
77
GSA Capital Partners
United Kingdom
-15,191 Closed
ARTA
78
A.R.T. Advisors
New York
-12,825 Closed
LCM
79
Laurion Capital Management
New York
-12,476 Closed
RAM
80
Riggs Asset Management
Pennsylvania
-11,600 Closed
KMWM
81
Keudell/Morrison Wealth Management
Oregon
-10,105 Closed
Cerity Partners
82
Cerity Partners
New York
-10,000 Closed
EWM
83
Edge Wealth Management
New York
-4,000 Closed
CAN
84
Cetera Advisor Networks
California
-665 Closed
PNC Financial Services Group
85
PNC Financial Services Group
Pennsylvania
-300 Closed
KPW
86
Kore Private Wealth
New York
-147 Closed
PAG
87
Private Advisor Group
New Jersey
-66 Closed
CAPTRUST Financial Advisors
88
CAPTRUST Financial Advisors
North Carolina
$0 58
First Manhattan
89
First Manhattan
New York
$0 94
CFGS
90
Concourse Financial Group Securities
Alabama
AssetMark Inc
91
AssetMark Inc
California
$0 9
OSAM
92
O'Shaughnessy Asset Management
Connecticut
$0 1
CTC
93
Central Trust Company
Missouri
$0 29
S
94
SignatureFD
Georgia
$0 400
HT
95
HAP Trading
New York
Susquehanna International Group
96
Susquehanna International Group
Pennsylvania
FWM
97
Focused Wealth Management
New York
$0 8
GRP
98
Global Retirement Partners
California
$0 9
LC
99
Lindbrook Capital
California
$0 29